Bora CDMO Bora CDMO

X

Find VS-6766 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

VS-6766
Also known as: 946128-88-7, Ro5126766, Ro-5126766, Ch5126766, Ro-5126766 free base, Avutometinib
Molecular Formula
C21H18FN5O5S
Molecular Weight
471.5  g/mol
InChI Key
LMMJFBMMJUMSJS-UHFFFAOYSA-N
FDA UNII
D0D4252V97

Avutometinib is an orally bioavailable inhibitor of the serine/threonine protein kinases Raf and mitogen-activated protein kinase kinase (MAP2K, MAPK/ERK kinase, or MEK), with potential antineoplastic activity. Upon oral administration, avutometinib specifically targets, binds to and inhibits the kinase activities of Raf and MEK, resulting in the inhibition of Raf/MEK-mediated signal transduction pathways. This results in the inhibition of Raf/MEK-dependent tumor cell proliferation and survival. The RAS/RAF/MEK/extracellular signal-regulated kinase (ERK) signaling pathway is often dysregulated in human cancers and plays a key role in tumor cell proliferation, differentiation and survival.
1 2D Structure

VS-6766

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[[3-fluoro-2-(methylsulfamoylamino)pyridin-4-yl]methyl]-4-methyl-7-pyrimidin-2-yloxychromen-2-one
2.1.2 InChI
InChI=1S/C21H18FN5O5S/c1-12-15-5-4-14(31-21-25-7-3-8-26-21)11-17(15)32-20(28)16(12)10-13-6-9-24-19(18(13)22)27-33(29,30)23-2/h3-9,11,23H,10H2,1-2H3,(H,24,27)
2.1.3 InChI Key
LMMJFBMMJUMSJS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C(=O)OC2=C1C=CC(=C2)OC3=NC=CC=N3)CC4=C(C(=NC=C4)NS(=O)(=O)NC)F
2.2 Other Identifiers
2.2.1 UNII
D0D4252V97
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ch5126766

2. Ro5126766

2.3.2 Depositor-Supplied Synonyms

1. 946128-88-7

2. Ro5126766

3. Ro-5126766

4. Ch5126766

5. Ro-5126766 Free Base

6. Avutometinib

7. Ro 5126766

8. Ch-5126766

9. Rg-7304

10. Cki-27

11. Ro5126766(ch5126766)

12. Chebi:78825

13. Ro 5126766 - Bio-x

14. Vs-6766

15. Chembl3264002

16. Ro5126766 (ch5126766)

17. D0d4252v97

18. R-7304

19. N-(3-fluoro-4-{[4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2h-chromen-3-yl]methyl}pyridin-2-yl)-n'-methylsulfuric Diamide

20. Sulfamide, N-(3-fluoro-4-((4-methyl-2-oxo-7-(2-pyrimidinyloxy)-2h-1-benzopyran-3-yl)methyl)-2-pyridinyl)-n'-methyl-

21. 3wig

22. Chu

23. Avutometinib [inn]

24. Schembl960093

25. Unii-d0d4252v97

26. Gtpl11867

27. Bcp21067

28. Ex-a2151

29. Bdbm50010462

30. Nsc758248

31. Nsc800871

32. S7170

33. Zinc68247388

34. Akos030527032

35. Ccg-269457

36. Compound 1 [pmid: 24900832]

37. Cs-5254

38. Db15254

39. Nsc-758248

40. Nsc-800871

41. Sb16628

42. Ro 5126766 [who-dd]

43. Ac-35949

44. Da-40233

45. Hy-18652

46. Ch 5126766

47. Ft-0737411

48. A916428

49. Ro5126766; Ch5126766

50. Q27147976

51. Ro 5126766; Ro5126766; Ch5126766; Ch5126766; Ch 5126766

52. 3-[(2-((n-methylsulfamoyl)amino)-3-fluoropyridin-4-yl)methyl]-4-methyl-7-(pyrimidin-2-yloxy)-chromen-2-one

53. 3-[[3-fluoro-2-(methylsulfamoylamino)pyridin-4-yl]methyl]-4-methyl-7-pyrimidin-2-yloxychromen-2-one

54. N-(3-fluoro-4-((4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2h-chromen-3-yl)methyl)pyridin-2-yl)-n'-methylsulfamide

2.4 Create Date
2007-08-27
3 Chemical and Physical Properties
Molecular Weight 471.5 g/mol
Molecular Formula C21H18FN5O5S
XLogP32
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count7
Exact Mass471.10126803 g/mol
Monoisotopic Mass471.10126803 g/mol
Topological Polar Surface Area141 Ų
Heavy Atom Count33
Formal Charge0
Complexity845
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY